Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 12 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 6 institutions in 3 countries.
Shabnam ShabirSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Amit SehgalSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Joydeep DuttaSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Inderpal DevgonSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Sandeep K SinghIndian Scientific Education and Technology Foundation, Lucknow 226002, Uttar Pradesh, India.ORCID 0000-0002-0022-6240
Walaa F AlsanieDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.
Abdulhakeem S AlamriDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0003-3174-0434
Majid AlhomraniDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0001-9798-0962
Abdulaziz AlsharifDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0003-1377-9247
Mohammed Abubaker Mohammed BasalamahDepartment of Pathology, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Hani FaidahDepartment of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Farkad BantunDepartment of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0002-7851-6977
Abdullah Ali SaatiDepartment of Community Medicine & Pilgrims Healthcare, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0003-3766-9915
Emanuel VamanuFaculty of Biotechnology, University of Agricultural Sciences and Veterinary Medicine, 011464 Bucharest, Romania.ORCID 0000-0002-3376-2058
Mahendra P SinghDepartment of Zoology and Centre of Genomics and Bioinformatics, DDU Gorakhpur University, Gorakhpur 273009, Uttar Pradesh, India.ORCID 0000-0002-6237-7191
Lovely Professional University · INTaif University · SAUmm al-Qura University · SADeen Dayal Upadhyaya Gorakhpur University · INUnited States India Educational Foundation · INUniversity of Agronomic Sciences and Veterinary Medicine of Bucharest · RO
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Nanotechnology holds significant ameliorative potential against neurodegenerative diseases, as it can protect the therapeutic substance and allow for its sustained release. In this study, the reducing and capping agents of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Therapeutic Potential of Green-Engineered ZnO Nanoparticles on Rotenone-Exposed · full record | OpenQuestion